196 related articles for article (PubMed ID: 28332308)
1. CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.
Ueshima C; Kataoka TR; Takei Y; Hirata M; Sugimoto A; Hirokawa M; Okayama Y; Blumberg RS; Haga H
Cancer Med; 2017 Apr; 6(4):845-856. PubMed ID: 28332308
[TBL] [Abstract][Full Text] [Related]
2. Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src.
Müller MM; Klaile E; Vorontsova O; Singer BB; Obrink B
J Cell Biol; 2009 Nov; 187(4):569-81. PubMed ID: 19948503
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function.
Chen D; Iijima H; Nagaishi T; Nakajima A; Russell S; Raychowdhury R; Morales V; Rudd CE; Utku N; Blumberg RS
J Immunol; 2004 Mar; 172(6):3535-43. PubMed ID: 15004154
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
[TBL] [Abstract][Full Text] [Related]
5. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
6. Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties.
Patel PC; Lee HS; Ming AY; Rath A; Deber CM; Yip CM; Rocheleau JV; Gray-Owen SD
J Biol Chem; 2013 Oct; 288(41):29654-69. PubMed ID: 24005674
[TBL] [Abstract][Full Text] [Related]
7. IRF-1 regulates alternative mRNA splicing of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in breast epithelial cells generating an immunoreceptor tyrosine-based inhibition motif (ITIM) containing isoform.
Dery KJ; Kujawski M; Grunert D; Wu X; Ngyuen T; Cheung C; Yim JH; Shively JE
Mol Cancer; 2014 Mar; 13():64. PubMed ID: 24650050
[TBL] [Abstract][Full Text] [Related]
8. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function.
Nakajima A; Iijima H; Neurath MF; Nagaishi T; Nieuwenhuis EE; Raychowdhury R; Glickman J; Blau DM; Russell S; Holmes KV; Blumberg RS
J Immunol; 2002 Feb; 168(3):1028-35. PubMed ID: 11801635
[TBL] [Abstract][Full Text] [Related]
9. Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36.
Chean J; Chen CJ; Gugiu G; Wong P; Cha S; Li H; Nguyen T; Bhatticharya S; Shively JE
J Biol Chem; 2021 Nov; 297(5):101311. PubMed ID: 34666041
[TBL] [Abstract][Full Text] [Related]
10. SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; degli Uberti EC
Endocrinology; 2005 Jun; 146(6):2692-8. PubMed ID: 15746253
[TBL] [Abstract][Full Text] [Related]
11. SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis.
Sugimoto A; Kataoka TR; Ueshima C; Takei Y; Kitamura K; Hirata M; Nomura T; Haga H
Exp Dermatol; 2018 Jun; 27(6):641-646. PubMed ID: 29498772
[TBL] [Abstract][Full Text] [Related]
12. The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity.
Lawson EL; Mills DR; Brilliant KE; Hixson DC
PLoS One; 2012; 7(1):e29606. PubMed ID: 22235309
[TBL] [Abstract][Full Text] [Related]
13. Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
Gaur S; Shively JE; Yen Y; Gaur RK
Mol Cancer; 2008 May; 7():46. PubMed ID: 18507857
[TBL] [Abstract][Full Text] [Related]
14. Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog.
Kammerer R; Popp T; Härtle S; Singer BB; Zimmermann W
BMC Evol Biol; 2007 Oct; 7():196. PubMed ID: 17945019
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of carcinoembryonic antigen-related cell adhesion molecule 1 in gastrointestinal cancer and its clinical relevance.
Zhou M; Jin Z; Liu Y; He Y; Du Y; Yang C; Wang Y; Hu J; Cui L; Gao F; Cao M
Acta Biochim Biophys Sin (Shanghai); 2017 Aug; 49(8):737-743. PubMed ID: 28655144
[TBL] [Abstract][Full Text] [Related]
16. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.
Kiriyama S; Yokoyama S; Ueno M; Hayami S; Ieda J; Yamamoto N; Yamaguchi S; Mitani Y; Nakamura Y; Tani M; Mishra L; Shively JE; Yamaue H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S505-14. PubMed ID: 24390710
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes.
Singer BB; Scheffrahn I; Heymann R; Sigmundsson K; Kammerer R; Obrink B
J Immunol; 2002 May; 168(10):5139-46. PubMed ID: 11994468
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo.
Wegwitz F; Lenfert E; Gerstel D; von Ehrenstein L; Einhoff J; Schmidt G; Logsdon M; Brandner J; Tiegs G; Beauchemin N; Wagener C; Deppert W; Horst AK
Oncotarget; 2016 Sep; 7(39):63730-63746. PubMed ID: 27572314
[TBL] [Abstract][Full Text] [Related]
19. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.
Liu W; Wei W; Winer D; Bamberger AM; Bamberger C; Wagener C; Ezzat S; Asa SL
Oncogene; 2007 Apr; 26(19):2747-58. PubMed ID: 17057731
[TBL] [Abstract][Full Text] [Related]
20. CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.
Yamaguchi S; Yokoyama S; Ueno M; Hayami S; Mitani Y; Takeuchi A; Shively JE; Yamaue H
J Surg Res; 2017 Dec; 220():353-362. PubMed ID: 29180203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
